...
首页> 外文期刊>Oncogene >Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.
【24h】

Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.

机译:功能获得突变体p53通过靶向转录因子FOXO3a和FOXM1来促进头颈部鳞状细胞癌细胞的致癌潜力。

获取原文
           

摘要

Many mutant p53 proteins exert oncogenic gain-of-function (GOF) properties that promote cancer cell invasive growth and metastasis, yet the mechanisms mediating these functions still largely remain elusive. We show here that overexpression of the GOF mutant p53 G245D and other GOF p53 mutants enhances the invasive cell growth of p53-deficient head and neck squamous cell carcinoma (HNSCC) UM-SCC-1 cells both in in vitro three-dimensional culture and in an in vivo orthotopic nude mouse model of HNSCC through a novel transcription-independent mechanism. We demonstrate that the expression of the oncogenic forkhead transcription factor FOXM1 is upregulated by GOF mutant p53s. Moreover, we show that overexpression of GOF mutant p53 G245D decreases the AMP-activated protein kinase (AMPK)-mediated phosphorylation of FOXO3a, a tumor suppressive forkhead transcription factor, leading to its cytoplasmic accumulation. This downregulation of FOXO3a's activity, in turn, leads to de-repression of FOXM1 expression. Importantly, we show that either overexpression of FOXO3a or downregulation of FOXM1 impairs both GOF mutant p53-mediated cell invasion in vitro and pulmonary metastases of UM-SCC-1 cells in vivo. Finally, not only do oral cancer patients with p53 mutations exhibit higher levels of FOXM1 expression than patients with wild-type p53, but also HNSCC patients with TP53 mutations and high levels of FOXM1 expression have the poorest survival outcomes. Given our prior demonstration that GOF mutant p53s inhibit AMPK, our current study, establishes and demonstrates a novel transcription-independent GOF mutant p53-AMPK-FOXO3a-FOXM1 signaling cascade that plays an important role in mediating mutant p53s' gain-of-function activities in HNSCCs.
机译:许多突变的p53蛋白发挥致癌作用的功能(GOF)特性,可促进癌细胞的侵袭性生长和转移,但是介导这些功能的机制在很大程度上仍然难以捉摸。我们在这里显示,GOF突变体p53 G245D和其他GOF p53突变体的过表达增强了p53缺陷型头颈部鳞状细胞癌(HNSCC)UM-SCC-1细胞在体外三维培养和体外培养中的侵袭性细胞生长。 HNSCC的体内原位裸鼠模型通过一种新型的转录独立机制。我们证明,致癌性叉头转录因子FOXM1的表达被GOF突变体p53s上调。此外,我们表明,GOF突变体p53 G245D的过表达降低了AMP激活的蛋白激酶(AMPK)介导的FOXO3a(一种肿瘤抑制性叉头转录因子)的磷酸化,导致其胞质积累。 FOXO3a活性的这种下调反过来导致FOXM1表达的抑制。重要的是,我们显示FOXO3a的过表达或FOXM1的下调都损害GOF突变体p53介导的体外细胞侵袭和体内UM-SCC-1细胞的肺转移。最后,不仅p53突变的口腔癌患者的FOXM1表达水平高于野生型p53,而且TP53突变和FOXM1表达水平高的HNSCC患者的生存结果最差。考虑到我们先前的证明,GOF突变体p53s抑制AMPK,我们目前的研究建立并证明了一种新型的转录独立性GOF突变体p53-AMPK-FOXO3a-FOXM1信号级联,在介导突变体p53s的功能获得活动中起着重要作用在HNSCC中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号